Browsing: News

The World Needs Science, and Science Needs Women. Recognised at the 2024 L’Oréal-UNESCO For Women in Science awards, these female Singaporean scientists are inspiring the next generation of diverse innovators.

Singapore’s BRAVE study, led by the Institute of Mental Health, invites up to 40,000 families to screen children aged 8–18 for ADHD, autism, and depression. Participants flagged at risk receive free diagnostic tests and guidance on follow-up care.

Novo Nordisk launches Wegovy in China, targeting the country’s 180 million people with obesity. Priced at ¥1,400 ($192 USD) per starter dose, it faces accessibility challenges as it’s not covered by national insurance. The move heightens competition with Eli Lilly.

The Singapore Red Cross reports a shortage of AB- and AB+ blood supplies, critical for emergencies and treatments. Hospitals use 15 blood units hourly, and one donation can save up to three lives. Here’s how you can make a difference!

Five tourists have died in Laos’ Vang Vieng due to suspected methanol poisoning from tainted alcohol. Global authorities are urging caution and advising travelers to buy drinks from trusted sources only. What is methanol poisoning and how can I protect myself?

Learn about #My1stProstateCheck, 365 Cancer Prevention Society’s free prostate cancer screening campaign, offering early detection and support for at-risk men.

At 58, Mike Tyson’s loss to Jake Paul revealed the toll boxing takes on ageing fighters, sparking concerns about safety and ethics. Do you think these organisations are prioritising entertainment over athletes’ health?

Singapore’s HPB partners with Google and Abbott on tech-driven programmes like HealthTrack SG and DigiCoach, using wearables and real-time insights to help manage diabetes and hypertension. These pilots focus on prevention and scalable solutions for better health outcomes.

Singapore’s OPTIMUM trial, a telemedicine study by SingHealth Polyclinics in collaboration with the MOH Office for Healthcare Transformation, empowered diabetes patients with tools for self-care and health monitoring. With promising results, this trial could pave the way for a national rollout in diabetes management.

FDA has banned oral phenylephrine after finding it ineffective for nasal congestion. This decision affects well-known cold medicines and raises questions in Singapore, where 14 products with this ingredient remain approved. The Health Sciences Authority is reviewing the issue.